Supplier profile
EXXEL TECHNOLOGIES S.A.E.
Every public-sector award we hold for this supplier, across Paraguay, from 20 Mar 2017 to 22 Jul 2025.
Awards won
113
all time
Attributed value
PYG 246.1bn
as published
Buyers
4
public bodies
Active
2017–2025
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Ministerio de Salud Pública y Bienestar Social (MSPBS) | 82 | PYG 94.1bn |
| Instituto de Previsión Social (IPS) | 27 | PYG 151.1bn |
| Ministerio del Interior (M.I.) | 3 | PYG 885.8m |
| Universidad Nacional de Asunción (UNA) | 1 | PYG 29.5m |
What they win
Awards
Showing 26–50 of 113 awards we hold
- CVE N° 46/22 ADQUISICION URGENTE DE LOS MEDICAMENTOS EMICIZUMAB 30MG/ML Y PALBOCICLIB 125MG ↗Instituto de Previsión Social (IPS)PYG 3.3bnawarded 16 Dec 2022
- ADQUISICIÓN DE MEDICAMENTOS VARIOS DECLARADOS DESIERTOS EN EL ID 406068 Y EN EL ID 406099 ↗Ministerio del Interior (M.I.)PYG 363.5mawarded 7 Dec 2022
- ADQUISICION DE PRODUCTOS MEDICINALES E INSUMOS MEDICOS PARA EL DPTO DE HEMATO ONCOLOGIA PEDIATRICA ↗Universidad Nacional de Asunción (UNA)PYG 29.5mawarded 30 Nov 2022
- CVE 73/2021 - ADQUISICION DE MEDICAMENTOS VEMURAFENIB 240 MG Y COBIMETINIB 20MG - AMPARO JUDICIAL ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 130.0mawarded 29 Nov 2022
- ADQUISICION DE MEDICAMENTO FULVESTRANT 250 MG, BEVACIZUMAB 400 MG, ANFOTERICINA 50 MG Y ENZALUTAMIDA 40 MG - AMPARO ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 107.4mawarded 23 Nov 2022
- CVE N° 86/21 ADQUISICIÓN DE MEDICAMENTO OCRELIZUMAB INYECTABLE 300 MG - AMPARO ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 241.9mawarded 21 Oct 2022
- CVE 09/2022 - ADQUISICION DE MEDICAMENTO CABAZITAXEL 60MG, ABIRATERONA 500MG, COBIMETINIB 20MG, VEMURAFENIB 240MG, ALECTINIB 150MG, PALBOCICLIB 125MG, SUNITINIB 50MG, LENVATINIB 10MG, LENVATINIB 4MG- AMPARO ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 377.3mawarded 13 Oct 2022
- CVE 23/22 ADQUISICION DE MEDICAMENTO CETUXIMAB 100 MG - AMPARO ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 2.4bnawarded 10 Oct 2022
- CVE N° 10/2022 - ADQUISICIÓN DE MEDICAMENTOS ALECTINIB 150MG, ADALIMUMAB 40 MG/0,4ML, ADALIMUMAB 40 MG/0,8ML, OCRELIZUMAB 300 MG, SUNITINIB 50 MG, PALBOCICLIB 125 MG - AMPARO. ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 431.2mawarded 5 Oct 2022
- CVE SBE 40-22 ADQUISICION URGENTE DEL MEDICAMENTO CETUXIMAB 100 MG PARA EL PACIENTE SR. VICENTE PINTO CHAMORRO ↗Instituto de Previsión Social (IPS)PYG 728.8mawarded 4 Oct 2022
- CVE 15/22 - "ADQUISICIÓN DE MEDICAMENTO DIMETILSULFOXIDO, BUSULFAN 6MG/ML, CARMUSTINA 100MG, MELFALAN 50MG, BOLSA CRIOGENICA, RIGORAFENIB 40MG, OCRELIZUMAB 300MG - AMPARO" ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 248.0mawarded 22 Sept 2022
- LPN N° 53/2022 ADQUISICIÓN DE FACTOR VII RECOMBINANTE PARA EL PROGRAMA NACIONAL DE SANGRE ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 3.3bnawarded 21 Sept 2022
- LPN SBE 103-19 ADQUISICION DE MEDICAMENTOS VARIOS PARA EL IPS - AD REFERENDUM 2020 ↗Instituto de Previsión Social (IPS)PYG 1.4bnawarded 15 Sept 2022
- LCO 05/22 - "ADQUISICIÓN DE MEDICAMENTO OCRELIZUMAB 300MG" ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 248.0mawarded 10 Jun 2022
- CVE N° 79/21 ADQUISICIÓN ATEZOLIMUMAB 840 MG Y NAB PACLITAXEL 100 MG - AMPARO JUDICIAL ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 402.2mawarded 25 May 2022
- LPN N° 95/21 ADQUISICIÓN DE MEDICAMENTOS E INSUMOS PARA EL PROGRAMA NACIONAL DE DIABETES. ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 6.8bnawarded 20 May 2022
- CVE 30-21 ADQUISICION URGENTE DE MEDICAMENTOS IMATINIB CRISTAL BETA 100 MG Y FACTOR VII RECOMBINANTE FORMULA EPTACOG ALFA LINEA CELULAR ANIMAL ↗Instituto de Previsión Social (IPS)PYG 3.2bnawarded 19 May 2022
- CVE N° 92/21 ADQUISICIÓN DE MEDICAMENTOS VEMURAFENIB 240 MG, COBIMETINIB 20 MG; LENVATINIB 10 MG Y 4 MG Y CARDIODESFIBRILADOR RESINCRONIZADOR E INSUMOS PARA CIRUGÍA CARDÍACA - AMPARO CONSTITUCIONAL ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 130.0mawarded 12 May 2022
- LPN N° 83/21 ADQUISICIÓN DE MEDICAMENTOS VARIOS PARA EL MSBYBS ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 1.2bnawarded 10 May 2022
- CVE N° 89/21 ADQUISICIÓN DE PALBOCICLIB 125 MG; FULVESTRANT 250 MG; IPILIMUMAB 50 MG; NIVOLUMAB 100 MG; ATEZOLIZUMAB 840 MG; PACLITAXEL 100 MG; ABEMACICLIB 150 MG ? AMPARO. ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 344.8mawarded 11 Apr 2022
- LCO N° 25/21 ADQUISICIÓN DE ADALIMUMAB 40 MG/0,8 ML AMPOLLA ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 547.0mawarded 9 Dec 2021
- LCO Nº 17/21"ADQUISICIÓN DE BASILIXIMAB 20MG INYECTABLE PARA EL INAT" ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 587.0mawarded 9 Dec 2021
- ADQUISICIÓN DE MEDICAMENTOS VARIOS PARA EL HOSPITAL DE POLICIA RIGOBERTO CABALLEROS ↗Ministerio del Interior (M.I.)PYG 14.8mawarded 1 Dec 2021
- CVE N° 54/21 - ADQUISICIÓN DE MEDICAMENTO BUSULFAN 6 MG, CARMUSTINA 100 MG, BOLSA CRIOGÉNICA, FLUDARABINA 50 MG, PALBOCICLIB 125 MG, ALECTINIB 150 MG - AMPARO ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 183.3mawarded 29 Nov 2021
- CVE Nº 50/21"ADQUISICION DE MEDICAMENTOS ONCOLOGICOS ATEZOLIZUMAB 1200MG-CABAZITAXEL 60MG-AMPARO" ↗Ministerio de Salud Pública y Bienestar Social (MSPBS)PYG 215.4mawarded 8 Nov 2021
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.